isradipine has been researched along with Muscular Dystrophies in 1 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
Muscular Dystrophies: A heterogeneous group of inherited MYOPATHIES, characterized by wasting and weakness of the SKELETAL MUSCLE. They are categorized by the sites of MUSCLE WEAKNESS; AGE OF ONSET; and INHERITANCE PATTERNS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caviedes, R | 1 |
| Caviedes, P | 1 |
| Liberona, JL | 1 |
| Jaimovich, E | 1 |
1 other study available for isradipine and Muscular Dystrophies
| Article | Year |
|---|---|
Ion channels in a skeletal muscle cell line from a Duchenne muscular dystrophy patient.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Bungarotoxins; Calcium Channels; Calcium Channels, L-Type; | 1994 |